Dino Delaportas, MD
Infectious Disease · Bridgeport, WVNPI 1639124159
Payments from drug & device makers
Across 1,017 payments — averaging $727.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$262K
- Melinta Therapeutics, LLC$111K
- AbbVie$107K
- Ferring Pharmaceuticals Inc.$87K
- Paratek Pharmaceuticals, Inc.$72K
- Cumberland Pharmaceuticals, Inc.$39K
- plus $62K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 51 | $261,670 |
| Melinta Therapeutics, LLC | 198 | $110,864 |
| AbbVie(2 entities) | 195 | $106,886 |
| Ferring Pharmaceuticals Inc. | 131 | $87,247 |
| Paratek Pharmaceuticals, Inc. | 142 | $71,619 |
| Cumberland Pharmaceuticals, Inc. | 78 | $39,425 |
| Merck | 77 | $31,881 |
| Insmed, Inc. | 64 | $24,079 |
| Shionogi Inc | 13 | $3,384 |
| Baudax Bio Inc. | 2 | $1,124 |
| Organogenesis Inc. | 10 | $292 |
| Smith+Nephew | 17 | $286 |
| La Jolla Pharmaceutical Company | 4 | $217 |
| Astellas Pharma US Inc | 5 | $171 |
| Lifenet Health | 5 | $113 |
| Accelerate Diagnostics Inc. | 2 | $69 |
| Bioventus LLC | 3 | $62 |
| Gilead | 4 | $61 |
| Misonix Inc | 3 | $55 |
| OVIK Health, LLC | 1 | $35 |
| Cipla USA Inc. | 1 | $35 |
| GRT US Holding, Inc. | 1 | $28 |
| Reprise Biomedical, Inc. | 1 | $23 |
| Invivyd Inc | 1 | $22 |
| Mylan Specialty L.p. | 1 | $19 |
| Hartmann USA, Inc. | 1 | $17 |
| Vyera Pharmaceuticals, LLC | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| GSK | 1 | $14 |
| Mckesson Patient Care Solutions Inc. | 1 | $12 |
| Kerecis Limited | 1 | $3 |
How this compares
$739,763 in reported general payments places this provider in the 95th percentile of 39 infectious disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Bridgeport
- Badiaa El-ImadBridgeport$618
- Jonathan StanleyBridgeport$68
- Zonaira GulBeckley$2K
- Archana VasudevanMorgantown$1K
- Leeja JosephHuntington$517
- Theresa HysellHuntington$486
- Mahmoud ShormanHuntington$482
- Rashida KhakooMorgantown$246
- Kara WillenburgHuntington$222
- Taras NebelukCharleston$187
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.